Hexagon Bio Is A Biopharmaceutical Company Based In Menlo Parkcaliforniafounded In 2016The Company Specializes In Discovering Novel Medicines By Utilizing The Global Metagenome And Microbial Genomesit Combines Computational Biology With Experimental Research To Develop Innovative Therapeuticsparticularly In The Field Of Oncology The Company Focuses On Creating Antibody Drug Conjugatesadcsby Mining Cytotoxic Small Molecules From Microbial Genomeshexagon Bio S Proprietary Platform Identifies Both Existing And Novel Payload Mechanismsincluding Topoisomerase And Tubulin Inhibitorsthe Company Is Advancing A Pipeline Of Next Generation Adc Candidates Aimed At Treating Various Solid Tumors And Hematological Malignancieswith Significant Funding And A Dedicated Teamhexagon Bio Is Committed To Addressing Critical Unmet Needs In Cancer Treatment
